CAMCEVI is a Subcutaneous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by Accord Biopharma, Inc.. The primary component is Leuprolide Mesylate.
| Product ID | 69448-014_d7a8761a-d954-413a-e053-2a95a90a60ee |
| NDC | 69448-014 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CAMCEVI |
| Generic Name | Leuprolide |
| Dosage Form | Injection, Emulsion |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2022-03-07 |
| Marketing Category | NDA / |
| Application Number | NDA211488 |
| Labeler Name | Accord BioPharma, Inc. |
| Substance Name | LEUPROLIDE MESYLATE |
| Active Ingredient Strength | 42 mg/.37g |
| Pharm Classes | Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-03-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CAMCEVI 90733116 not registered Live/Pending |
Foresee Pharmaceuticals Co., Ltd. 2021-05-25 |
![]() CAMCEVI 87953162 not registered Live/Pending |
FORESEE PHARMACEUTICALS, Co LTD. 2018-06-07 |